Ocuphire Presents APX3330 ZETA-1 Clinical Data in Late-Breaker Session at the American Diabetes Association’s Annual Conference Jun 27, 2023
Ocuphire Announces Late Breaking Presentation on APX3330 ZETA-1 Clinical Data at American Diabetes Association Annual Conference Jun 21, 2023
Ocuphire Pharma Announces Financial Results for First Quarter 2023 and Provides Corporate Update May 15, 2023
Ocuphire Provides Corporate Update and Reiterates Previous Guidance on Clinical Programs Apr 25, 2023
Ocuphire Pharma Announces Financial Results for Fourth Quarter and Year Ended 2022 and Provides Corporate Update Mar 30, 2023